These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7318145)

  • 21. Development of an in vitro colony formation assay for the evaluation of in vivo chemotherapy of a rat brain tumor.
    Rosenblum ML; Knebel KD; Wheeler KT; Barker M; Wilson CB
    In Vitro; 1975; 11(5):264-73. PubMed ID: 1184035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
    Zhang RX; Dougherty DV; Rosenblum ML
    Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy.
    Moon TE; Salmon SE; White CS; Chen HS; Meyskens FL; Durie BG; Alberts DS
    Cancer Chemother Pharmacol; 1981; 6(3):211-8. PubMed ID: 7318144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term culture of pediatric brain tumors.
    Mackillop WJ; Blundell J; Steele P
    Childs Nerv Syst; 1985; 1(3):163-8. PubMed ID: 4042106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine.
    Roosen N; Doz F; Yeomans KL; Dougherty DV; Rosenblum ML
    Cancer Chemother Pharmacol; 1994; 34(5):385-92. PubMed ID: 7520843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of malignant brain tumors: comparison of the in vitro activities of vidarabin-monophosphate, BCNU and 5-fluorouracil.
    Bogdahn U; Weber H; Zapf J; Dünisch G; Löbering HG; Mertens HG
    Acta Neurol Scand; 1987 Jan; 75(1):28-36. PubMed ID: 3577665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil.
    Gerosa MA; Dougherty DV; Wilson CB; Rosenblum ML
    J Neurosurg; 1983 Mar; 58(3):368-73. PubMed ID: 6827321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of clonogenic human brain tumour cells: preliminary results of tumour sensitivity testing with BCNU.
    Rosenblum ML; Dougherty DA; Deen DF; Hoshino T; Wilson CB
    Br J Cancer Suppl; 1980 Apr; 4():181-5. PubMed ID: 6252931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain.
    Honess DJ; Bleehen NM
    Br J Cancer; 1982 Aug; 46(2):236-48. PubMed ID: 6758828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemosensitivity testing for human brain tumors.
    Rosenblum ML
    Prog Clin Biol Res; 1980; 48():259-76. PubMed ID: 7208520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three tumor sensitivity tests evaluated with mouse tumors.
    Lelieveld P; Mulder JH
    Int J Cell Cloning; 1987 Jul; 5(4):335-46. PubMed ID: 3476675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of 9-10 anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone]dihydrochloride (CL216,942) in a human tumor cloning system. Leads for phase II trials in man.
    Von Hoff DD; Coltman CA; Forseth B
    Cancer Chemother Pharmacol; 1981; 6(2):141-4. PubMed ID: 7307232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an automated image analysis system for counting human tumor colonies.
    Salmon SE; Young L; Lebowitz J; Thomson S; Einsphar J; Tong T; Moon TE
    Int J Cell Cloning; 1984 May; 2(3):142-60. PubMed ID: 6736686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular heterogeneity in malignant tumors. The importance of clonal interaction on tumor evolution, response to chemotherapy and metastatic ability evaluated in experimental systems.
    Aabo K
    Dan Med Bull; 1996 Sep; 43(4):336-49. PubMed ID: 8884135
    [No Abstract]   [Full Text] [Related]  

  • 35. [Difference in colony growth and drug sensitivity between human gastric and colorectal cancers in clonogenic assay].
    Mizuno Y
    Nihon Geka Hokan; 1984 Mar; 53(2):371-7. PubMed ID: 6508465
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of in vitro chemosensitivity assays: human tumor clonogenic and scintillation assay].
    Tanigawa N; Morimoto H; Akita T; Inoue H; Tanaka T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1176-84. PubMed ID: 3729439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.
    Bogdahn U; Zapf J; Weber H; Dünisch G; Löbering HG; Martin R; Mertens HG
    Br J Cancer; 1987 Feb; 55(2):153-8. PubMed ID: 2434122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of clumps and clusters on survival measurements with clonogenic assays.
    Rockwell S
    Cancer Res; 1985 Apr; 45(4):1601-7. PubMed ID: 3978627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentials and drawbacks of the human tumor stem cell assay.
    Shoemaker RH; Wolpert-DeFilippes MK; Venditti JM
    Behring Inst Mitt; 1984 May; (74):262-72. PubMed ID: 6477356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro analysis of the cellular resistance to chemotherapeutic BCNU.
    Caballero Navarro A; Conde Guerri B; Sinues Porta E; Boada Apilluelo E; Alcalá Arellano A
    Histol Histopathol; 1992 Jul; 7(3):347-51. PubMed ID: 1504454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.